Heart Failure

U.S. FDA approves V-V timing in Medical Epic HF and Atlas+ HF CRT-Ds

Published in Medical Letter on the CDC and FDA, December 19th, 2004

St. Jude Medical, Inc., (STJ) announced that it has received U.S. Food and Drug Administration (FDA) approval to add V-V (ventricle to ventricle) timing to new models of the St. Jude Medical Epic HF and Atlas+ HF family of cardiac resynchronization therapy devices (CRT-Ds).

The company believes it is the first CRT-D supplier in the U.S. market to offer this expanded programmability.

Shipment was expected to begin December 1, 2004.

"We're excited to be the first medical-device manufacturer to bring programmable V-V timing in high-voltage cardiac resynchronization devices to the U.S. market," said Michael J. Coyle, president of St....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-12-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry